Robert S. Kiss
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Editorial: Endocrinology, lipids, and disease: unraveling the links.
Journal: Frontiers in endocrinology
Published: August 18, 2025
Reducing CETP activity prevents memory decline in an Alzheimer's disease mouse model.
Journal: EMBO molecular medicine
Published: March 25, 2025
Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646].
Journal: Metabolism: clinical and experimental
Published: September 19, 2024
Foam fractionation studies of recombinant human apolipoprotein A-I.
Journal: Biochimica et biophysica acta. Biomembranes
Published: May 20, 2024
Isolation of recombinant apolipoprotein E4 N-terminal domain by foam fractionation.
Journal: Protein expression and purification
Published: May 17, 2023
PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.
Journal: Metabolism: clinical and experimental
Published: April 21, 2023
Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.
Journal: The Journal of biological chemistry
Published: March 16, 2023
High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells.
Journal: Frontiers in cardiovascular medicine
Published: March 12, 2022
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages.
Journal: BBA advances
Published: January 27, 2021
Proprotein convertase 7 (PCSK7) reduces apoA-V levels.
Journal: The FEBS journal
Published: August 07, 2019
Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte.
Journal: Clinical science (London, England : 1979)
Published: January 13, 2017
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA.
Journal: The Journal of biological chemistry
Published: November 24, 2016
Last Updated: 09/26/2026